← RIGEL PHARMACEUTICALS INC RIGL
Market Price
$42.36
Market Cap
$755.81M
P/E Ratio
2.17
Revenue (FY 2025)
↑64.1% YoY
$294.28M
3-Yr CAGR: 34.8%
Net Income
↑1,999.1% YoY
$367.02M
Net Margin: 124.7%
Free Cash Flow
↑140.7% YoY
$75.66M
FCF Yield: 10.01%
EPS (Diluted)
↑1,867.7% YoY
$19.48
Basic: $20.40
Return on Equity
Efficiency
93.8%
ROA: 1,672.7%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (RIGL)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2017: Revenue YoY (-78.0%) is identical to Gross Profit YoY (-78.0%). Verify the underlying Revenue and Gross Profit values for FY 2017 and FY 2016.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $20.4M | — | $18.3M | $-69.2M | — | — | — | $-75.9M | $-76.7M | — |
| FY 2017 | $4.5M | -78.0% | $4.0M | $-78.0M | -12.7% | — | — | $-77.6M | $-77.7M | -1.3% |
| FY 2018 | $44.5M | +892.6% | $44.2M | $-70.5M | +9.6% | — | — | $-58.8M | $-59.9M | +22.9% |
| FY 2019 | $59.3M | +33.2% | $58.4M | $-66.9M | +5.1% | — | — | $-41.5M | $-43.0M | +28.3% |
| FY 2020 | $108.6M | +83.2% | $107.3M | $-29.7M | +55.5% | — | — | $-52.2M | $-53.4M | -24.4% |
| FY 2021 | $149.2M | +37.4% | $144.4M | $-17.9M | +39.8% | $-0.11 | — | $5.9M | $5.3M | +109.8% |
| FY 2022 | $120.2M | -19.4% | $116.5M | $-58.6M | -227.0% | $-0.34 | -209.1% | $-73.8M | $-74.2M | -1,513.2% |
| FY 2023 | $116.9M | -2.8% | $109.8M | $-25.1M | +57.2% | $-0.14 | +58.8% | $-5.7M | $-5.7M | +92.3% |
| FY 2024 | $179.3M | +53.4% | $160.6M | $17.5M | +169.7% | $0.99 | +807.1% | $31.5M | $31.4M | +647.4% |
| FY 2025 | $294.3M | +64.1% | $274.7M | $367.0M | +1,999.1% | $19.48 | +1,867.7% | $75.7M | $75.7M | +140.7% |
Valuation
Market Price
$42.36
Market Cap
$755.81M
Enterprise Value
$767.73M
P/E Ratio
2.17
P/B Ratio
2.00
FCF Yield
10.01%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
93.33%
Operating Margin
42.63%
Net Margin
124.72%
Return on Equity (ROE)
93.75%
Return on Assets (ROA)
1,672.70%
Asset Turnover
13.41x
Revenue 3-Yr CAGR
34.76%
Financial Health & Liquidity
Current Ratio
0.22
Cash Ratio
0.41
Debt / Equity
0.134
Debt / Assets
2.393
Cash & Equivalents
$40.58M
Total Debt
$52.50M
Book Value / Share
$21.16
Cash Flow Efficiency
Operating Cash Flow
$75.66M
Capital Expenditures (CapEx)
N/A
Free Cash Flow
$75.66M
OCF / Revenue
25.71%
FCF / Revenue
25.71%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$19.48
EPS (Basic)
$20.40
Dividends / Share
N/A
Book Value / Share
$21.16
EPS YoY Growth
1,867.68%
Balance Sheet (FY 2025)
Total Assets
$21.94M
Total Liabilities
$99.24M
Stockholders' Equity
$391.48M
Current Assets
$21.94M
Current Liabilities
$99.24M